{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T08:57:35Z","timestamp":1783587455060,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.retram.2024.103476","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T19:05:33Z","timestamp":1730315133000},"page":"103476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation and management of hepatic dysfunction, portal hypertension and portal\/splanchnic vein thrombosis in patients with myelofibrosis undergoing allogeneic haematopoietic cell transplantation: A practice based survey on behalf of the Chronic Malignancies Working Party of the EBMT"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0695-3879","authenticated-orcid":false,"given":"Giorgia","family":"Battipaglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Polverelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Tuffnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Chiusolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Robin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Gambella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annoek","family":"Broers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Passweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Furst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone Smidtrup","family":"Friis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remy","family":"Dulery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moniek","family":"de Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha","family":"Srour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Finazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Wehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Bethge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Drozd-Sokolowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Czerw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Hern\u00e1ndez-Boluda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donal P.","family":"McLornan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.retram.2024.103476_bib0001","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2018.206151","article-title":"State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019","author":"McLornan","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.retram.2024.103476_bib0002","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/bloodadvances.2019001426","article-title":"Guidance on changing therapy choice in myelofibrosis","volume":"4","author":"McLornan","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.retram.2024.103476_bib0003","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(21)00438-4","article-title":"Current and future status of JAK inhibitors","volume":"398","author":"McLornan","year":"2021","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.retram.2024.103476_bib0004","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1182\/blood-2014-04-572545","article-title":"MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis","volume":"124","author":"Rondelli","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.retram.2024.103476_bib0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2141.2010.08417.x","article-title":"Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle et de Th\u00e9rapie Cellulaire (SFGM-TC): allogeneic HSCT for myelofibrosis","volume":"152","author":"Robin","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2024.103476_bib0006","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41375-020-0815-z","article-title":"Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation","volume":"35","author":"Hern\u00e1ndez-Boluda","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.retram.2024.103476_bib0007","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/IJGM.S51800","article-title":"Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes","author":"Verstovsek","year":"2014","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.retram.2024.103476_bib0008","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.clml.2014.04.004","article-title":"Clinical features of patients with philadelphia-negative myeloproliferative neoplasms complicated by portal hypertension","volume":"15","author":"Yan","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.retram.2024.103476_bib0009","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41409-019-0741-8","article-title":"Pulmonary hypertension is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation for myelofibrosis","volume":"55","author":"Gupta","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.retram.2024.103476_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/cancers15010011","article-title":"Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment considerations and unmet needs","volume":"15","author":"Liu","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.retram.2024.103476_bib0011","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.1182\/blood-2022-156076","article-title":"Early hepatotoxicity in patients with myelofibrosis after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)","volume":"140","author":"Robin","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.retram.2024.103476_bib0012","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/ajh.26654","article-title":"Innovative strategies to improve hematopoietic stem cell transplant outcomes in myelofibrosis","volume":"97","author":"Perram","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.retram.2024.103476_bib0013","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/S2352-3026(22)00330-1","article-title":"Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a position paper on behalf of the Chronic Malignancies Working Party of the EBMT","volume":"10","author":"Polverelli","year":"2023","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.retram.2024.103476_bib21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/ajh.27262","article-title":"Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT","volume":"99","author":"Polverelli","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.retram.2024.103476_bib0014","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/bloodadvances.2021006318","article-title":"Patient-specific comorbidities as prognostic variables for survival in myelofibrosis","volume":"7","author":"Sochacki","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.retram.2024.103476_bib0015","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.3390\/jcm9072149","article-title":"Organ stiffness in the work-up of myelofibrosis and Philadelphia-negative chronic myeloproliferative neoplasms","volume":"9","author":"Benedetti","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.retram.2024.103476_bib0016","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3324\/haematol.2019.245407","article-title":"Elastography improves accuracy of early hepato-biliary complications diagnosis after allogeneic stem cell transplantation","volume":"106","author":"Debureaux","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.retram.2024.103476_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/673781","article-title":"Portal hypertension and myeloproliferative neoplasms: a relationship revealed","volume":"2013","author":"Toros","year":"2013","journal-title":"ISRN Hematol"},{"key":"10.1016\/j.retram.2024.103476_bib0018","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/hep.1840120515","article-title":"Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: a clinicopathological study of 145 patients examined at autopsy","volume":"12","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.retram.2024.103476_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.853138","article-title":"Optimal treatment for patients with cavernous transformation of the portal vein","volume":"9","author":"Wei","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.retram.2024.103476_bib0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ajh.26020","volume":"96","author":"Polverelli","year":"2021","journal-title":"Am J Hematol"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318624000382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318624000382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T07:51:45Z","timestamp":1744876305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318624000382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2452318624000382"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2024.103476","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation and management of hepatic dysfunction, portal hypertension and portal\/splanchnic vein thrombosis in patients with myelofibrosis undergoing allogeneic haematopoietic cell transplantation: A practice based survey on behalf of the Chronic Malignancies Working Party of the EBMT","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2024.103476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"103476"}}